Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome

Mayo Clinic Proceedings

Volumn 77, Issue 5, 2002, Pages 413-421

  Ackerman, Michael J ^a,b   Khositseth, Anant ^a   Tester, David J ^a   Hejlik, Joseph B ^a   Shen, Win Kuang ^a   Porter, Co Burn J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

ECG = electrocardiogram; LQTS = long QT syndrome; NSVT = nonsustained ventricular tachycardia; PVCs = premature ventricular contractions; QTc = corrected QT interval; TWA = T wave alternans

Indexed keywords

ADRENALIN;

ADOLESCENT; ADULT; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MALE; PATIENT MONITORING; PROVOCATION TEST; QT INTERVAL; SCHOOL CHILD;

EID: 0036237833     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.5.413     Document Type: Article

References (28)

1. Molecular and cellular mechanisms of cardiac arrhythmias
2. Ion channels - Basic science and clinical disease
3. The long QT syndrome: Ion channel diseases of the heart
4. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
5. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
6. Molecular mechanism for an inherited cardiac arrhythmia
7. Mapping of a gene for long QT syndrome to chromosome 4q25-27
8. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel
9. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
10. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
11. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome
12. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome
13. Diagnostic accuracy of screening electrocardiograms in long QT syndrome I
14. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome
15. Low penetrance in the long-QT syndrome: Clinical impact
16. Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome
17. Autonomic mechanisms and sudden death: New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction
18. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects
19. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
20. Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome
21. Molecular autopsy of sudden unexplained death in the young
22. Epinephrine-induced changes in serum potassium and cardiac repolarization and effects of pretreatment with propranolol and diltiazem
23. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
24. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome
25. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
26. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes
27. Requirement of a macromolecular signaling complex for β adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel
28. Diagnostic criteria for the long QT syndrome: An update